Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 759, pseudogene (RNU6-759P) is a pseudogene belonging to the U6 small nuclear RNA (snRNA) gene family[1]. U6 snRNA is typically a core component of the spliceosome in eukaryotes, catalyzing removal of introns from pre-mRNA during RNA splicing[3][5]. However, RNU6-759P is not an active gene but a pseudogene; it does not encode a functional RNA molecule, and there is no evidence it serves as a protein, receptor, enzyme, or drug target[1]. Pseudogenes can sometimes play regulatory roles (such as serving as miRNA decoys or creating noncoding RNAs that affect parental gene regulation)[2], but there are no data suggesting RNU6-759P has such roles, nor is it associated with any disease or drug interaction. This target is not a therapeutic target, and its inclusion as a target is likely incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 759, pseudogene (RNU6-759P).